Holen Sie sich die Stockscreener-App
1.12
6.13%
0.06
Handel nachbörslich:
1.12
Schlusskurs vom Vortag:
$1.06
Offen:
$1.06
24-Stunden-Volumen:
44,952
Relative Volume:
0.14
Marktkapitalisierung:
$3.14M
Einnahmen:
$4.96M
Nettoeinkommen (Verlust:
$-6.82M
KGV:
-0.0171
EPS:
-65.4
Netto-Cashflow:
$-6.64M
1W Leistung:
-7.79%
1M Leistung:
-14.77%
6M Leistung:
-63.11%
1J Leistung:
-76.56%
1-Tages-Spanne:
$1.055
$1.1363
1-Wochen-Bereich:
$1.03
$1.24
52-Wochen-Spanne:
$1.03
$8.27
Inmed Pharmaceuticals Inc Stock (INM) Company Profile
Firmenname
Inmed Pharmaceuticals Inc
Sektor
Telefon
(604) 669-7207
Adresse
1445-885 WEST GEORGIA ST., VANCOUVER
Vergleichen Sie INM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INM
Inmed Pharmaceuticals Inc
|
1.12 | 2.97M | 4.96M | -6.82M | -6.64M | -65.40 |
|
ZTS
Zoetis Inc
|
125.90 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Inmed Pharmaceuticals Inc Aktie (INM) Neueste Nachrichten
InMed Pharmaceuticals (NASDAQ:INM) Trading Up 5% – Time to Buy? - Defense World
Indian Infotech and Software Limited At Critical Juncture Bounce or BreakdownGlobal Trade Effects & Budget Friendly Portfolio Growth - earlytimes.in
InMed faces challenges from new US legislation - MSN
What dividend safety score for InMed Pharmaceuticals Inc. stockJuly 2025 Highlights & Real-Time Volume Trigger Notifications - Улправда
Risk Check: Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull market - Улправда
Surprises Report: What Wall Street predicts for InMed Pharmaceuticals Inc. stock price2025 Momentum Check & Advanced Technical Analysis Signals - Улправда
Growth Value: Why hedge funds are buying InMed Pharmaceuticals Inc. stock2025 Bull vs Bear & Real-Time Price Movement Reports - Улправда
Can InMed Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Market Summary & Stepwise Trade Signal Implementation - Улправда
Day Trade: How analysts revise price targets for InMed Pharmaceuticals Inc. (MWG) stockJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда
Why hedge funds are buying InMed Pharmaceuticals Inc. stockJuly 2025 Trends & Stepwise Entry and Exit Trade Signals - Улправда
InMed Shareholders Approve Directors and Equity Financing Flexibility - TipRanks
InMed Pharmaceuticals (INM) investors approve directors, auditor and 20%+ SEPA share issuance - Stock Titan
InMed Announces Results of 2025 Annual General and Special Meeting - Investing News Network
Drug developer's investors sign off on potential 20% new share issuance - Stock Titan
InMed Pharmaceuticals (INM) director details employee stock option expiry - Stock Titan
InMed Pharmaceuticals (INM) CEO Eric Adams details 250-option expiry - Stock Titan
InMed Pharmaceuticals Inc. (INM) discloses COO stock option expiration - Stock Titan
InMed Pharmaceuticals (INM) reports senior VP employee option expiration - Stock Titan
InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET - TMX Newsfile
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025 - TMX Newsfile
Dated alerts on InMed Pharmaceuticals withdrawn - marketscreener.com
InMed Faces Challenges from New U.S. Legislation - TipRanks
InMed Pharmaceuticals Inc Evaluates Impact of New US Legislation on Subsidiary - TradingView — Track All Markets
InMed Pharmaceuticals (NASDAQ: INM) files update on H.R. 5371 impact - Stock Titan
Aquestive Therapeutics (NASDAQ:AQST) and InMed Pharmaceuticals (NASDAQ:INM) Head to Head Comparison - Defense World
InMed Provides Update on BayMedica Commercial Business - TMX Newsfile
Life Sciences Virtual Investor Forum Agenda Announced for December 11th - The Manila Times
Analysis Recap: Why hedge funds are buying InMed Pharmaceuticals Inc stockJuly 2025 Momentum & Community Consensus Trade Signals - BỘ NỘI VỤ
What insider trading reveals about InMed Pharmaceuticals Inc. stock2025 Stock Rankings & Expert Approved Momentum Ideas - Newser
Why InMed Pharmaceuticals Inc. (MWG) stock attracts HNW investorsMarket Growth Report & Expert Approved Momentum Trade Ideas - Newser
Is InMed Pharmaceuticals Inc. (MWG) stock worth buying before Fed actionShare Buyback & AI Powered Market Entry Ideas - Newser
Is InMed Pharmaceuticals Inc. (MWG) stock considered safe havenDollar Strength & High Conviction Investment Ideas - Newser
InMed Pharmaceuticals Inc. (INM) AI-Powered Stock Analysis - Meyka
Why pension funds invest in InMed Pharmaceuticals Inc. (MWG) stock2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Will InMed Pharmaceuticals Inc. (MWG) stock rise with strong economyWeekly Volume Report & Verified Stock Trade Ideas - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
InMed Pharmaceuticals (INM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is InMed Pharmaceuticals Inc. (MWG) stock a top hedge fund pick2025 Price Targets & Smart Swing Trading Techniques - Newser
Will New Partnerships Boost Dhampur Sugar Mills Limiteds OutlookInsider Trading Compliance & Small Investment Portfolio - earlytimes.in
How InMed Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will InMed Pharmaceuticals Inc. (MWG) stock remain on Wall Street radarPrice Action & Real-Time Volume Trigger Notifications - Newser
Is InMed Pharmaceuticals Inc. (MWG) stock a good hedge against inflation2025 Technical Overview & Advanced Technical Analysis Signals - Newser
What market sentiment indicators show for InMed Pharmaceuticals Inc. (MWG) stockWeekly Stock Summary & Expert Curated Trade Setup Alerts - Newser
Is InMed Pharmaceuticals Inc MWG a good long term investmentStock Price Targets & Budget Friendly Investment Plans - earlytimes.in
Finanzdaten der Inmed Pharmaceuticals Inc-Aktie (INM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.19%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):